Artemisinin-Polypyrrole Conjugates: Synthesis, DNA Binding Studies and Preliminary Antiproliferative Evaluation

Greater than the sum of its parts: Artemisinins are currently in phase I–II clinical trials against breast, colorectal and non‐small‐cell lung cancers. In an attempt to offer increased specificity, a series of hybrid artemisinin–polypyrrole minor groove binder conjugates are described. DNA binding/m...

Full description

Saved in:
Bibliographic Details
Published inChemMedChem Vol. 8; no. 5; pp. 709 - 718
Main Authors La Pensée, Louise, Sabbani, Sunil, Sharma, Raman, Bhamra, Inder, Shore, Emma, Chadwick, Amy E., Berry, Neil G., Firman, James, Araujo, Nuna C., Cabral, Lília, Cristiano, Maria L. S., Bateman, Cerys, Janneh, Omar, Gavrila, Adelina, Wu, Yi Hang, Hussain, Afthab, Ward, Stephen A., Stocks, Paul A., Cosstick, Rick, O'Neill, Paul M.
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 01.05.2013
WILEY‐VCH Verlag
Wiley
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Greater than the sum of its parts: Artemisinins are currently in phase I–II clinical trials against breast, colorectal and non‐small‐cell lung cancers. In an attempt to offer increased specificity, a series of hybrid artemisinin–polypyrrole minor groove binder conjugates are described. DNA binding/modelling studies and preliminary biological evaluation give insights into their mechanism of action and the potential of this strategy.
Bibliography:British Engineering and Physical Sciences Research Council (EPSRC)
ArticleID:CMDC201200536
istex:37E20EDCF83A0F3E2E2CEB27046CEBF02996E7C9
EU FP6 Malaria Initiative ANTIMAL
ark:/67375/WNG-PX6STWLB-Q
These authors contributed equally to this work.
researchfish
UKRI
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1860-7179
1860-7187
DOI:10.1002/cmdc.201200536